METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
Salvato in:
GLANZ, M., ET AL., METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION. AMERICAN JOURNAL ON ADDICTIONS, Vol. 6, no. 4 (1997), p. 339-349.
Ref.
64322
Localizzazione:
SIIS R.1264
Palabras clave:
Alternativas, Drogodependencias, Evaluación, Fármacos, Metadona, Opiáceos, Tratamiento médico
Alternativas, Drogodependencias, Evaluación, Fármacos, Metadona, Opiáceos, Tratamiento médico
Documenti analoghi: METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
- LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION
- A RANDOMIZED TRIAL COMPARING LEVO-ALPHA ACETYLMETHADOL WITH METHADONE MAINTENANCE FOR PATIENTS IN PRIMARY CARE SETTING IN AUSTRALIA